Upregulated expression of CLU has been linked to increased chemoresistance in multiple cancer types including the breast, lung, prostate, bladder, liver, pancreatic, ovarian, cervical, melanoma and osteosarcoma [26, 38]. The gene discussed is CLU; the disease is cancer.